Submit Manuscript  

Article Details


Treatment of Clopidogrel Hypersensitivity: The Jefferson Approach

[ Vol. 17 , Issue. 2 ]

Author(s):

Alec Vishnevsky, Michael P. Savage and David L. Fischman*   Pages 123 - 126 ( 4 )

Abstract:


Despite the advent of newer antiplatelet therapies, clopidogrel remains the mainstay of treatment for patients with cardiovascular disease, especially those who undergo coronary stent implantation. Hypersensitivity reactions to clopidogrel that develop soon after stenting present a significant clinical challenge. The widespread use of clopidogrel in the management of patients with coronary artery disease necessitates awareness of treatment options in the setting of an allergic reaction. It has been demonstrated that clopidogrel hypersensitivity can be successfully managed without interrupting clopidogrel therapy. We review available treatment options and highlight the treating-through approach developed at our institution.

Keywords:

Clopidogrel, hypersensitivity, allergy, percutaneous coronary intervention, hypersensitivity treatment, ACS.

Affiliation:

Division of Cardiology, Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107, Division of Cardiology, Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107, Division of Cardiology, Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107

Graphical Abstract:



Read Full-Text article